Form 4: NeuroOne Medical Technologies Executive Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 90 shares of common stock on April 30, 2024, to satisfy tax withholding obligations.
Summary
- On April 30, 2024, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, disposed of 90 shares of common stock.
- The transaction was executed to cover tax obligations arising from an unspecified event.
- The shares were disposed of at a price of $1.13 per share.
- Following the transaction, Christianson directly owns 323,114 shares of NeuroOne Medical Technologies Corp.
- The transaction was reported on May 2, 2024.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive sold a small number of shares to cover tax obligations, which is a routine transaction.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This transaction is a common occurrence where shares are disposed of to cover tax obligations.
Stakeholder Impact
- The disposal of a small number of shares by an executive is unlikely to have a significant impact on shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/30/2024 | Date of transaction: Mark Christianson disposed of 90 shares of common stock. |
| 05/02/2024 | Date of report: The Form 4 was signed and filed on this date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.